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CLINICAL mastitis has the largest economic impact on the
dairy cattle industry. Despite intensive bacteriological
research, 20 to 35 per cent of clinical cases of bovine mastitis
have an unknown aetiology (Miltenburg and others 1996,
Barkema and others 1998). Although viral infections have
occasionally been associated with bovine mastitis (Siegler and
others 1984, Yoshikawa and others 1997), it is generally con-
sidered that viruses do not play a role in the aetiology of
bovine mastitis (Watts 1988, Radostits and others 1994). This
study was undertaken to gain more insight into the possible
role of viruses in bovine clinical mastitis, due to the high
percentage of unknown causes of clinical mastitis.
In a case/control study, serum and milk samples were col-
lected from 58 dairy cows with clinical mastitis in 10 differ-
ent Dutch herds at the acute (day 0) and the convalescent
phase (day 21) of the disease. Serum and milk samples were
also taken from 58 healthy, matched control cows. The con-
trol cows were from the same herd, did not show mastitis
symptoms, were of the same age as the mastitis cows and were
in the same stage of lactation as the mastitis cows. Milk sam-
ples from the matched control cows were collected on the
same day from the same quarters as the affected quarters of
the corresponding clinical mastitis cases. The milk samples
were collected as described by the National Mastitis Council
(Harmon and others 1990). Samples for virus isolation were
stored directly at -70°C, while milk samples for the screen-
ing of bacterial agents were stored at 2 to 4°C, and usually cul-
tured within 24 hours. Blood samples were obtained from the
median sacral vein of the tail, and centrifuged at 2000 g for 10
minutes. Sera were stored at -20°C.
After sampling on day 0, cows with clinical mastitis were
treated with antibiotics; the matched controls were not
treated. Convalescent samples were taken at least two weeks
after the last antibiotic medication. The number of lactating
cows in the 10 different herds varied between 31 and 57, and
the number of case/control pairs varied from one to 22 per
herd (Table 1). Milk samples were examined for the presence
of viruses, using four different types of cell cultures: embry-
onic bovine trachea cells (EBTr; a semipermanent cell line
developed in the authors' laboratory, ID-Lelystad); bovine
epithelial udder cells (including fibroblasts) (Schmid and oth-
ers 1983); bovine umbilical cord endothelial (BUE) cells (Van
de Wiel and others 1989); and bovine alveolar lung
macrophages obtained from specific pathogen free (SPF)
cattle (Schrijver and others 1995).
The milk samples were thawed, defatted by centrifugation
at 1500 g for 10 minutes, and 0-5 ml of the defatted milk was
used for virus isolation. For the virus isolation on
macrophages, 100 1d of defatted milk samples were pipetted
into the wells of a 96-well cell culture plate, containing 3 to 5
x 104 cells per well. The inoculated cells were incubated for
five to seven days at 37°C, with 5 per cent carbon dioxide for
the macrophages. After a freeze/thaw cycle, a second passage
was performed. During the first and the second passages, the
cell cultures were observed every day for a cytopathogenic
effect (cpe). Four controls were included in each cell culture
run. Two controls, containing 10'and 103 median tissue cul-
ture infective dose (TCID50) of bovine herpesvirus 1 (BHV-1)
per millilitre of milk, served as positive controls. A milk sam-
ple without viruses and a plain cell culture control, served as
negative controls. After the second passage, a haemadsorption
reaction, for the detection of, for example, Orthomyxoviridae
and Paramyxoviridae, was performed on EBTr cells with 0-2 per
cent guinea pig erythrocytes, and incubated at 370C for one
hour. An EBTr cell culture inoculated with parainfluenza virus
3 was used as a positive control. Electron microscopy (EM) was
performed after the second passages for all four cell types. A
400 mesh carbon-coated nickel grid with a collodion film was
floated on a drop of the inoculated cell cultures for five min-
utes, drained onto filter paper and stained with 2 per cent
phosphotungstic acid (pH 6-8). The grids were examined by
transmission EM after drying.
Serum samples collected from mastitis cows were exam-
ined for antibodies against BHV-1 by ELISA (Kramps and oth-
ers 1994), against bovine herpesvirus 2 (BHV-2) by a 24-hour
virus neutralisation test (Bushnell and Edwards 1988), against
bovine herpesvirus 4 (BHV-4) by ELISA (Wellenberg and oth-
ers 1999), against bovine respiratory syncytial virus (BRSV) by
ELISA (Westenbrink and others 1985), against bovine viral
diarrhoea virus (BVDV) by ELISA (Westenbrink and others
1986), against bovine leukaemia virus (BLV) by ELISA
(Pourquier), and against adenovirus type 3 by ELISA (BIO-X).
In case blocking percentages, ELISA coefficients or optical den-
sity values indicated a significant increase in antibody titre,
the serum samples were titrated by serial two-fold dilution
steps. The control cows were only examined for antibodies
against BHV-4, because only a few cows with clinical mastitis
seroconverted (where seroconversion is defined as a seroneg-
ative acute serum and a seropositive convalescent serum)
against viruses other than BHV-4. Serum samples containing
antibodies against BHV-4, were titrated by serial two-fold dilu-
tion steps. A four-fold (two dilution steps) higher antibody
titre in convalescent serum compared with acute serum is
defined as a significant increase.
Bacteriological culture of the milk samples was performed
according to standards of the National Mastitis Council
(Harmon and others 1990). Milk samples (0-01 ml) were
inoculated on 6 per cent blood agar plates (both aerobically
and anaerobically), on TCT medium (Thallium sulphate,
Crystal Violet, Staphylococcus f-toxin; Merck) and on
MacConkey number 3 agar (Oxoid). The plates were incu-
bated at 370C and bacterial growth was evaluated after both
24 and 48 hours. Bacterial colonies were identified as
described by the National Mastitis Council (Harmon and oth-
ers 1990). Bacteria were considered to be pathogenic or non-
pathogenic, on the basis of the description by Barkema and
others (1998) which, in some cases, depended on the number
of colonies isolated.
No cpe was observed during the first and second passages
in EBTr cell cultures, bovine udder epithelial cells, or
macrophages that were inoculated with milk samples from
the cows with clinical mastitis. No virus particles were
detectable in these cell cultures by EM. The haemadsorption
reaction, performed on EBTr cell cultures after the second pas-
sage, was negative for all these samples. The BUE cell cultures
inoculated with milk samples from cow 49 (day 0), and cow
400 (day 21) of herd 8 and herd 10, respectively, showed cpe
six to seven days after inoculation. Herpesvirus particles were
detected by EM in the BUE cell cultures inoculated with milk
from cow 12 of herd 9 (day 0 and day 21). No virus particles
were detected in all the other milk samples from cows with
clinical mastitis and the matched control cows by virus iso-
lation on BUE cells, or by EM. The results of virus isolation on
herd level and on an individual level are given in Tables 1 and
2, respectively. The three virus isolates were characterised as
herpesviruses by EM. The virus isolates and control BHV-4 ref-
erence strains DN-599 and LVR 140, were partly neutralised with
monospecific antiserum against BHV-4, and not with mono-
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M 1 2 3 4 5 6 7
Pathogenic bacteria in milk (day 0)
M C
1 1 -/- 1/- Escherichia coli
2 7 -/- 1/3 E coli (x2), Streptococcus uberis (x2)
3 3 -/- 3/1
4 22 -/- 2/1 CNS (x2), E coli (x2), Staphylococcus
aureus (x2), S uberis (x3)
5 1 -/- -/- CNS
6 1 -/- 1/1
7 2 -- 1/- S aureus, S aureus + S aureus
Arcanobacterium pyogenes
8 3 1/- 1/1 S uberis, Streptococcus dysgalactiae
9 10 1/- -/1 E coli, S aureus (x2), E coli + S uberis, S aureus (x2)
CNS (x2), S dysgalactiae, S uberis
10 8 1/- 2/4 A pyogenes, Corynebacterium C bovis (x3)
bovis (x2), S uberis
Total 58 3/- 12/12 31 6
M Mastitis cows, C Control cows, CNS Coagulase-negative staphylococci
specific antisera against BHV-1 and BHV-2. In an immunoper-
oxidase monolayer assay, the three virus isolates and the
BHV-4 reference strains DN-599 and LVR 140 reacted with mon-
oclonal antibody 123 which is directed against glycoprotein 1
of BHV-4 (Dubuisson and others 1992), while BHV-1, BHV-2 and
bovine herpesvirus 5 (BHV-5) did not react with monoclonal
antibody 123. Restriction enzyme analyses of DNA from the
virus isolates, and the BHV-4 reference strains DN-599, Movar
33/63 and LVR 140, showed that the patterns of the virus iso-
lates were comparable to those of the BHV-4 reference strain
Movar 33/63 (Fig 1). Statistical analysis, using the sign test,
indicated that BHV-4 was more frequently isolated from
mastitis cows than from controls (P=O 125).
BHV-4
Antibody
Virus development (serum)*
Case/ isolation Acute Convalescent
Herd Cow control from milk phase phase Pathogenic bacteria in milk (day 0)
1 24 Case - - - Escherichia coli (sporadic)
Control - - 800 Corynebacterium bovis (day 21)
4 16 Case - - 800
Control - - -
33 Case - - 400
Control - - 400
37 Case - - 200
Control - - 400
51 Case - 100 400
Control - - -
54 Case - 100 400 Streptococcus uberis (sporadic)
Control - - -
8 49 Case + 100 400 S uberis
Control - - -
52 Case - - - Streptococcus dysgalactiae
Control - 200 800
9 28 Case - - 800 S uberis and E coli
Control - - -
22 Case - - - Staphylococcus aureus
Control - - 200 S aureus (day 21)
12 Case + - - E coli
Control - - -
10 275 Case - - 100 Arcanobacterium pyogenes
Control - 200 800
400 Case + - 200 S uberis
Control
* Antibody titres expressed as the reciprocal of the highest serum dilution giving a positive
reaction
- Not detected, + Detected
212
5-1
3-5
15-4O09
FIG 1: Restriction endonuclease analysis of viral DNA digested
with EcoRI. Lane 1 Bovine herpesvirus 4 (BHV-4) DN-599
strain, Lane 2 BHV-4 Movar 33/63 strain, Lane 3 BHV-4 LVR 140
strain, Lane 4 BHV-4 strain from herd 8 (day 0), Lane 5 BHV-4
strain from herd 9 (day 0), Lane 6 BHV-4 strain from herd 9
(day 21), Lane 7 BHV-4 strain from herd 10 (day 21), M Marker.
Molecular mass standards (in kb) are identified on the left
Two of the three cows from which BHV-4 was isolated,
developed antibodies against BHV-4 (cow 49 and cow 400),
while no antibodies against BHV-4 were detectable in cow 12
within 21 days. No development in BHV-4 antibodies was
detected in the three corresponding control cows of these
three cows (Table 2). In herd 4, which had a large number
of clinical mastitis cases, five cows with clinical mastitis
developed antibodies against BHV-4 at the time mastitis
occurred. In total, 16 per cent of the mastitis cows and 10 per
cent of the controls developed antibodies against BHV-4.
However, development of antibodies against BHV-1, BRSV or
adenovirus type 3 was detected in only four cows with clin-
ical mastitis, but none of these viruses was isolated from the
milk. In the sera of these four cows, no antibodies against
BHV-4 were detected. No development of antibodies was
detected against BHV-2, BVDV or BLV in the sera from all 58
cows with clinical mastitis.
Pathogenic bacteria were isolated in 31 (53 per cent) of the
58 milk samples from clinical mastitis cows that were col-
lected on day 0 (Table 1). Streptococcus uberis was also isolated
from the milk samples of cow 49 in herd 8 on day 0 (day 21;
not determined), and cow 400 in herd 10 both on day 0 and
day 21 (Table 2). Escherichia coli was isolated from the milk of
cow 12 (herd 9) on day 0 and day 21. Fisher's exact test
showed that there was a significant positive association
between BHV-4 isolation and S uberis isolation (P=0.02).
This is the first report on the isolation of BHV-4 from milk
from cows with clinical mastitis. Although BHV-4 DN-599
strains have been isolated from udder lesions from lactating
dairy cows with mammary pustular dermatitis (Reed and
others 1977), and BHV-4 has been isolated from the cellular
fraction of a milk sample collected from a cow with chronic
ulcerative mammary dermatitis (Cavirani and others 1990),
BHV-4 has never been identified as a possible cause of bovine
mastitis. The three cows from which BHV-4 was isolated did
not show mammary dermatitis or teat lesions. BHV-4 DN-599
strain was also recovered from milk samples after experi-
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mental inoculation via the teat channel, showing that viral
multiplication can occur after injection into the mammary
gland (Osorio and Reed 1983).
The following findings further support a role of BHV-4
infection in bovine mastitis: in four of the 10 herds of this
study there was an ongoing BHV-4 infection at the same time
as clinical mastitis occurred; in herd 4, where more than 50
per cent of the dairy cows showed clinical mastitis problems
per year, five (23 per cent) mastitis cows showed serocon-
version or a significant increase in antibody titre against BHV-
4, compared with two (9 per cent) controls (Table 2); in four
of the five mastitis cows of this herd no pathogenic bacteria
were isolated from milk, only a few colonies of S uberis were
isolated from the milk of the fifth cow; of all 58 mastitis cows,
16 per cent developed antibodies against BHV-4, and 10 per
cent of the 58 control cows did so, but because subclinical
mastitis was not included in the case population, the latter
relatively high percentage might partially be explained by the
fact that some control cows had subclinical mastitis. Support
for this explanation is the finding that in milk samples of two
control cows that developed antibodies against BHV-4,
Corynebacterium bovis (herd 1) or Staphylococcus auireus
(herd 9) were isolated, both on day 21 only (Table 2); in nine
of the 10 herds studied, antibodies against BHV-4 were preva-
lent, whereas only 57 per cent of 30 randomly chosen Dutch
herds had antibodies against BHV-4 (Wellenberg and others
1999).
Whether BHV-4 may play a direct and/or indirect role in the
pathogenesis of bovine mastitis remains to be clarified. The
finding that four cows developed antibodies against BHV-4 at
the time of clinical mastitis and that no pathogenic aerobic or
anaerobic bacteria were isolated from these cows, suggests
BHV-4 as a primary cause. On the other hand, the concomitant
isolation of BHV-4 and of S u4beris or E coli, both known to
cause severe clinical mastitis (Barkema and others 1998), sug-
gests that BHV-4 infection of the udder may lead to a higher
susceptibility for bacterial infections. Vanopdenbosch and
others ( 1984) reported that BHV-4 could induce immunosup-
pression favouring the development of secondary infections
in cattle. Infected splenic mononuclear cells and peripheral
blood leucocytes persistently infected with BHV-4 (Osorio and
Reed 1983) could reduce the phagocytic function of these
cells. This enhances the possibility for bacterial infections to
run a more severe course which, in turn, may result in pro-
longed bacterial infections. On the other hand, cases of clin-
ical mastitis, that is, induced by S uberis, could lead to
reactivation of latent BHV-4 infection, which in turn may also
enhance the severity of mastitis cases.
The fact that this the first report on the isolation of BHV-4
in milk samples from cows with clinical mastitis may be
explained by the use of BUE cells which are seldom used in
bovine virology. These cells appear to be much more suscep-
tible to BHV-4 than other bovine cells, for example, several
BHV-4 strains reached 20- to 3000-fold higher titres in BUE cells
than in EBTr cells (data not shown). The susceptibility of
endothelial cells to BHV-4 has recently been reported by Lin
and others (1997).
In conclusion, these results demonstrate that BHV-4 may
play a role in clinical mastitis in dairy cows. Whether BHV-4
plays a primary or secondary role in the pathogenesis of
bovine clinical mastitis needs to be elucidated. The authors
are currently performing experimental infections with the
BHV-4 isolate to attempt to reproduce bovine mastitis, and to
fulfil Koch's postulates.
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Preputial diverticulum
stone in a boar
J. W. TYLER, D. M. WEAVER, M. D. SHORE,
R. P. COWART, K. BRANSON, J. URDAZ
FIG 1: Stone removed from the right horn of the preputial
diverticulum in a male Vietnamese potbellied pig
AN intact male three-year-old Vietnamese potbellied pig was
presented with a preputial swelling of several month's dura-
tion. The owner reported that the pig had no apparent dis-
comfort associated with either urination or breeding. Physical
examination revealed a firm, circumscribed 4 cm swelling in
the subcutaneous tissues approximately 3 cm lateral to the
preputial orifice in the area of the right horn of the preputial
diverticulum. No other abnormalities were observed on phys-
ical examination. The owner requested that the mass be
removed.
The boar was fasted overnight and then premedicated with
0-007 mg/kg medetomedine (Domitor; Pfizer) intramuscu-
larly, 0-2 mg/kg butorphanol (Torbugesic; Fort Dodge) intra-
muscularly, and 0-02 mg/kg atropine (Atropine sulfate;
Phoenix). Anaesthesia was induced by intravenous adminis-
tration of 10 mg/kg ketamine (Ketaset; Fort Dodge) and the
pig was intubated. Anaesthesia was maintained by inhalation
of isoflurane, the pig was positioned in dorsal recumbency,
and the ventral abdomen was prepared for the aseptic surgi-
cal removal of the mass.
Allis tissue forceps were inserted through the orifice of the
preputial diverticulum and both horns of the diverticulum
were explored. The left horn was partially everted, examined,
and no abnormalities were observed. A firm mass was iden-
tified within the lumen of the right horn and this horn could
not be everted.
A paramedian skin incision was made directly over the
right horn of the preputial diverticulum, and the divertic-
ulum was dissected free from the surrounding subcutaneous
tissues. The base of the right horn was ablated using a cir-
cumferential ligature of 0 polyglactin (Vicryl; Ethicon) and
the right horn was transected distal to the ligature. The
removed diverticulum horn was incised and a 4 cm stone
was identified (Fig 1). Subcutaneous tissues were closed with
2-0 polyglactin (Vicryl; Ethicon) in a simple continuous pat-
tern and the skin was closed using a braided, non-absorbable
suture (2-0 polyamid; Schering-Plough Animal Health) in a
continuous lock stitch. Recovery from anaesthesia was
uneventful. Postoperative antibiotics (22,000 iu/kg procaine
penicillin G) were administered and no postoperative com-
plications were observed. The skin sutures were removed 12
days postoperatively, and the pig was reported to be normal
two months after surgery. The preputial stone, or divertic-
ulith, was submitted for diagnostic analysis, and was found
to be composed of magnesium ammonium phosphate
(struvite).
The preputial diverticulum of male swine is a bilobed
structure with an orifice located in the dorsal aspect of the
FIG 2: Diagram of the preputial diverticulum of a boar (a). The
prepuce (b), preputial orifice (c) and the free portion of the
penis (d) can also be seen
cranial aspect of the prepuce (Fig 2). The paired lobes of the
diverticulum are located in the subcutaneous tissues cranial
and lateral to the preputial orifice (Roberts 1971, Engel and
St Clair 1981). Techniques for removal of the diverticulum
have been described as treatments for localised infection or,
alternatively, for aesthetic considerations (Aamdal and others
1958, Lawhorn and others 1994, Powe 1998). Occasionally,
diverticuli are removed when boars develop the vice of repet-
itive diverticular masturbation, which limits a boar's breed-
ing capacity (Cutler and others 1981).
Although the potential for concretions and preputial cal-
culi to form in the preputial diverticulum has been alluded to
by Roberts (1971), the present case is, to the authors' knowl-
edge, the first report of a preputial diverticulith in a boar.
Conditions observed in Vietnamese potbellied swine may or
may not be representative of domestic swine raised for agri-
cultural purposes.
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